MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 81 filers reported holding MEIRAGTX HLDGS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $218,446 | -25.0% | 44,490 | +2.6% | 0.00% | – |
Q2 2023 | $291,446 | +49.1% | 43,370 | +14.7% | 0.00% | – |
Q1 2023 | $195,426 | -17.2% | 37,800 | +4.4% | 0.00% | – |
Q4 2022 | $236,024 | -17.2% | 36,200 | +6.8% | 0.00% | – |
Q3 2022 | $285,000 | +15.9% | 33,900 | +4.3% | 0.00% | – |
Q2 2022 | $246,000 | -42.9% | 32,500 | +4.5% | 0.00% | – |
Q1 2022 | $431,000 | -41.4% | 31,100 | +0.3% | 0.00% | – |
Q4 2021 | $736,000 | +80.0% | 31,000 | 0.0% | 0.00% | – |
Q3 2021 | $409,000 | -15.0% | 31,000 | 0.0% | 0.00% | – |
Q2 2021 | $481,000 | +15.6% | 31,000 | +7.6% | 0.00% | – |
Q1 2021 | $416,000 | -9.0% | 28,800 | -4.6% | 0.00% | – |
Q4 2020 | $457,000 | +21.2% | 30,200 | +6.0% | 0.00% | – |
Q3 2020 | $377,000 | +0.3% | 28,500 | -5.0% | 0.00% | – |
Q2 2020 | $376,000 | +13.6% | 30,000 | +22.0% | 0.00% | – |
Q1 2020 | $331,000 | -5.4% | 24,600 | +40.6% | 0.00% | – |
Q4 2019 | $350,000 | +46.4% | 17,500 | +16.7% | 0.00% | – |
Q3 2019 | $239,000 | -27.8% | 15,000 | +22.0% | 0.00% | – |
Q2 2019 | $331,000 | – | 12,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
PA Capital LLC | 39,039 | $525,000 | 0.46% |